Biotypes of Central Nervous System Complications in People With Human Immunodeficiency Virus: Virology, Immunology, and Neuropathology.


Journal

The Journal of infectious diseases
ISSN: 1537-6613
Titre abrégé: J Infect Dis
Pays: United States
ID NLM: 0413675

Informations de publication

Date de publication:
17 03 2023
Historique:
received: 21 06 2022
entrez: 17 3 2023
pubmed: 18 3 2023
medline: 22 3 2023
Statut: ppublish

Résumé

Despite viral suppression with antiretroviral therapy (ART), people with human immunodeficiency virus (HIV) continue to experience central nervous system (CNS) complications, primarily in the form of mild cognitive impairment and mental health disorders (eg, depression, anxiety, other neuropsychiatric problems). The multifactorial pathogenesis and heterogeneity of mechanisms likely underlying CNS complications must be addressed in the development of preventive interventions and effective treatments. The biotyping approach has previously been useful to define phenotypes of other CNS diseases based on underlying mechanisms and could be translated to the field of neuroHIV. The purpose of the Biotype Workshop series, and the Virology, Immunology and Neuropathology Working Group in particular, is to capitalize on current and new technologies and guide future research efforts using the wealth of available immunological, virologic, and neuropathological data collected from people with HIV on and off ART.

Identifiants

pubmed: 36930640
pii: 7079927
doi: 10.1093/infdis/jiac370
pmc: PMC10022721
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

S3-S15

Subventions

Organisme : NIMH NIH HHS
ID : R25 MH108389
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH125737
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG063846
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH118990
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS117458
Pays : United States
Organisme : NIAID NIH HHS
ID : UM1 AI164567
Pays : United States
Organisme : NIMH NIH HHS
ID : P30 MH062512
Pays : United States
Organisme : NIAID NIH HHS
ID : T32 AI007384
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA050491
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH125720
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI147849
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA047879
Pays : United States
Organisme : NIAID NIH HHS
ID : UM1 AI126619
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA051890
Pays : United States
Organisme : NIMH NIH HHS
ID : R21 MH122243
Pays : United States
Organisme : NIAID NIH HHS
ID : P30 AI036214
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG063659
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH125396
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH106466
Pays : United States
Organisme : NIDA NIH HHS
ID : U01 DA053625
Pays : United States
Organisme : NIMH NIH HHS
ID : U24 MH100931
Pays : United States
Organisme : NIAID NIH HHS
ID : UM1 AI164559
Pays : United States
Organisme : NIDA NIH HHS
ID : UM1 DA051410
Pays : United States
Organisme : NIMH NIH HHS
ID : R24 MH129166
Pays : United States

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America.

Références

J Virol. 2009 Mar;83(6):2575-83
pubmed: 19129457
J Clin Invest. 2020 Apr 1;130(4):1699-1712
pubmed: 31910162
J Virol. 2013 Jul;87(13):7218-33
pubmed: 23616655
J Cancer Surviv. 2020 Aug;14(4):483-493
pubmed: 32157609
J Neuroimmune Pharmacol. 2019 Mar;14(1):120-133
pubmed: 29981000
J Virol. 2019 Dec 12;94(1):
pubmed: 31597764
J Neurovirol. 2018 Dec;24(6):695-701
pubmed: 30105502
AIDS. 2020 Jun 1;34(7):963-978
pubmed: 32379159
Arch Neurol. 2012 Jan;69(1):72-7
pubmed: 22232345
J Infect Dis. 2019 Nov 6;220(12):1867-1869
pubmed: 30668742
J Acquir Immune Defic Syndr. 2013 Apr 15;62(5):487-95
pubmed: 23242157
Trends Immunol. 2015 Oct;36(10):569-577
pubmed: 26431936
Nat Rev Neurol. 2016 Apr;12(4):234-48
pubmed: 26965674
J Neurovirol. 2011 Feb;17(1):3-16
pubmed: 21174240
Curr Opin Infect Dis. 2022 Jun 1;35(3):223-230
pubmed: 35665716
J Infect Dis. 2017 Dec 27;217(1):69-81
pubmed: 29069436
Cereb Cortex. 2018 Oct 1;28(10):3578-3588
pubmed: 28968847
Neurol Neuroimmunol Neuroinflamm. 2019 Apr 04;6(3):e551
pubmed: 31119186
J Leukoc Biol. 2010 Apr;87(4):621-6
pubmed: 20130221
J Clin Invest. 2019 Jul 15;129(8):3339-3346
pubmed: 31305262
J Neurovirol. 2022 Feb;28(1):54-63
pubmed: 34874540
Clin Infect Dis. 2019 May 2;68(10):1739-1746
pubmed: 30137250
PLoS Pathog. 2012;8(5):e1002686
pubmed: 22693444
J Virol. 2009 Nov;83(21):11016-26
pubmed: 19692480
J Leukoc Biol. 2003 Nov;74(5):650-6
pubmed: 12960230
PLoS Pathog. 2021 Dec 7;17(12):e1010105
pubmed: 34874976
Virology. 2007 Mar 30;360(1):105-19
pubmed: 17084877
Curr HIV/AIDS Rep. 2019 Feb;16(1):82-95
pubmed: 30661180
Lancet. 1997 Mar 8;349(9053):692-5
pubmed: 9078201
AIDS. 2012 Sep 10;26(14):1765-74
pubmed: 22614889
Open Forum Infect Dis. 2017 May 25;4(3):ofx108
pubmed: 28680905
Neurology. 2015 Sep 29;85(13):1139-45
pubmed: 26320196
AIDS. 2019 Dec 1;33 Suppl 2:S145-S157
pubmed: 31789815
J Virol. 2002 Jun;76(12):6277-92
pubmed: 12021361
J Infect Dis. 2007 Jun 15;195(12):1774-8
pubmed: 17492593
Neurology. 2007 Oct 9;69(15):1536-41
pubmed: 17923616
Proc Natl Acad Sci U S A. 2013 Aug 13;110(33):13588-93
pubmed: 23898208
PLoS Pathog. 2014 Dec 11;10(12):e1004533
pubmed: 25502752
PLoS One. 2016 Jun 13;11(6):e0157160
pubmed: 27295036
AIDS. 2018 Sep 24;32(15):2171-2178
pubmed: 30005007
Clin Infect Dis. 2022 Aug 31;75(3):493-502
pubmed: 34747481
Nat Immunol. 2017 Feb;18(2):123-131
pubmed: 28092374
AIDS Res Ther. 2010 Jun 03;7:15
pubmed: 20525234
AIDS. 2021 Nov 1;35(13):2129-2136
pubmed: 34115648
PLoS One. 2021 May 13;16(5):e0250987
pubmed: 33983973
J Neurovirol. 2018 Dec;24(6):665-669
pubmed: 30397827
Cell Rep. 2017 Feb 7;18(6):1473-1483
pubmed: 28178524
Neurol Neuroimmunol Neuroinflamm. 2014 Oct 09;1(3):e36
pubmed: 25340088
J Exp Med. 2001 Apr 16;193(8):905-15
pubmed: 11304551
Int J STD AIDS. 2001 Feb;12(2):79-83
pubmed: 11236108
Brain Behav Immun Health. 2020 May;5:100078
pubmed: 32382727
Clin Infect Dis. 2019 Sep 27;69(8):1345-1352
pubmed: 30561541
Neuropsychopharmacology. 2021 Jan;46(1):143-155
pubmed: 32979849
J Neurovirol. 2015 Feb;21(1):66-80
pubmed: 25522787
J Virol. 1991 Nov;65(11):6094-100
pubmed: 1920627
J Infect Dis. 2011 Dec 15;204(12):1936-45
pubmed: 22021620
J Acquir Immune Defic Syndr. 2010 Dec 15;55(5):590-6
pubmed: 20847699
PLoS One. 2014 Dec 26;9(12):e116081
pubmed: 25541953
Medicine (Baltimore). 2020 Jun 12;99(24):e20516
pubmed: 32541474
Nat Med. 2017 Jan 6;23(1):16-17
pubmed: 28060802
Neurology. 2020 Mar 10;94(10):436-448
pubmed: 32047067
J Infect Dis. 2016 Oct 1;214 Suppl 2:S67-74
pubmed: 27625433
Expert Rev Mol Diagn. 2017 Aug;17(8):761-770
pubmed: 28598205
Proc Natl Acad Sci U S A. 2006 Oct 10;103(41):15160-5
pubmed: 17015824
PLoS Pathog. 2015 Mar 26;11(3):e1004720
pubmed: 25811757
Am J Psychiatry. 2016 Apr 1;173(4):373-84
pubmed: 26651391
AIDS. 2013 Jun 1;27(9):1387-95
pubmed: 23435298
Virus Evol. 2016 Aug 03;2(2):vew020
pubmed: 27774305
PLoS One. 2020 Jul 22;15(7):e0236162
pubmed: 32697807
PLoS One. 2017 Aug 23;12(8):e0183594
pubmed: 28832681
Neurology. 2010 Dec 7;75(23):2087-96
pubmed: 21135382
PLoS One. 2017 Apr 26;12(4):e0176460
pubmed: 28445506
Brain Pathol. 1991 Apr;1(3):163-75
pubmed: 1669705
PLoS One. 2014 Feb 11;9(2):e88591
pubmed: 24523921
J Neurovirol. 2009 Sep;15(5-6):360-70
pubmed: 20175693
Brain Behav. 2021 Dec;11(12):e2415
pubmed: 34758203
JCI Insight. 2021 Jun 8;6(11):
pubmed: 33914710
J Virol. 2004 Jul;78(13):6915-26
pubmed: 15194768
PLoS Pathog. 2017 Jan 3;13(1):e1006112
pubmed: 28046096
Ann Neurol. 2010 Jun;67(6):699-714
pubmed: 20517932
J Infect Dis. 2013 Jun 1;207(11):1703-12
pubmed: 23460748
AIDS. 2021 Jul 15;35(9):1403-1412
pubmed: 33813555
J Infect Dis. 2011 Jul 1;204(1):154-63
pubmed: 21628670
J Infect Dis. 2019 Nov 6;220(12):1885-1891
pubmed: 30668739
Neurol Neuroimmunol Neuroinflamm. 2014 Sep 04;1(3):e27
pubmed: 25340079
PLoS Pathog. 2021 Sep 23;17(9):e1009871
pubmed: 34555123
Ann Neurol. 1995 Nov;38(5):755-62
pubmed: 7486867
Blood. 2011 Aug 4;118(5):e16-31
pubmed: 21653326
Clin Infect Dis. 2018 Sep 28;67(8):1182-1190
pubmed: 29617912
Ther Adv Infect Dis. 2019 Apr 04;6:2049936119838228
pubmed: 31001421
J Infect Dis. 2012 Jul 15;206(2):275-82
pubmed: 22551810
J Antimicrob Chemother. 2012 Feb;67(2):299-311
pubmed: 22160207
Curr HIV Res. 2016;14(5):373-381
pubmed: 27719663
Virology. 2006 Mar 1;346(1):169-79
pubmed: 16309726
Schizophr Bull. 2014 Mar;40 Suppl 2:S131-7
pubmed: 24562492
J Exp Med. 2017 Jul 3;214(7):1913-1923
pubmed: 28606987
EBioMedicine. 2015 Nov 22;3:135-140
pubmed: 26870824
J Infect Dis. 2018 Mar 13;217(7):1024-1032
pubmed: 29401308
Neurology. 1993 Nov;43(11):2230-7
pubmed: 8232935
J Neurol. 2013 Feb;260(2):620-6
pubmed: 23052602
Int J STD AIDS. 2013 May;24(5):351-5
pubmed: 23970701
J Virol. 2014 Feb;88(4):1858-69
pubmed: 24307580
J Virol. 2001 Nov;75(21):10073-89
pubmed: 11581376
J Neurol. 2007 Aug;254(8):1026-32
pubmed: 17420923
PLoS Pathog. 2011 Oct;7(10):e1002286
pubmed: 22007152
JCI Insight. 2018 Sep 20;3(18):
pubmed: 30232286
Xenobiotica. 2019 Oct;49(10):1192-1201
pubmed: 30346892
J Virol. 2009 Aug;83(16):8208-20
pubmed: 19515785
J Virol. 1999 Dec;73(12):9741-55
pubmed: 10559284
J Virol. 2018 May 14;92(11):
pubmed: 29563297
PLoS One. 2016 Feb 01;11(2):e0147182
pubmed: 26829391
Front Neurol. 2021 Apr 01;12:628296
pubmed: 33868143
J Acquir Immune Defic Syndr. 2018 Sep 1;79(1):108-116
pubmed: 29781885
Clin Infect Dis. 2018 Aug 16;67(5):770-777
pubmed: 29506084
Clin Infect Dis. 2019 Jan 18;68(3):490-497
pubmed: 30107467
J Infect Dis. 2008 May 15;197 Suppl 3:S294-306
pubmed: 18447615
J Acquir Immune Defic Syndr. 2017 May 1;75(1):108-117
pubmed: 28177966
Curr HIV/AIDS Rep. 2022 Feb;19(1):113-120
pubmed: 34822063
AIDS. 2016 Jan 28;30(3):415-23
pubmed: 26765935
J Virol. 2012 Mar;86(5):2715-28
pubmed: 22190722
Am J Pathol. 2006 Mar;168(3):822-34
pubmed: 16507898
J Infect Dis. 2019 Jun 5;220(1):68-72
pubmed: 30561665
AIDS. 2014 Jun 1;28(9):1297-306
pubmed: 24637542
Curr HIV/AIDS Rep. 2012 Mar;9(1):52-63
pubmed: 22237899
Clin Infect Dis. 2010 Mar 1;50(5):773-8
pubmed: 20100092
PLoS Pathog. 2020 Jun 11;16(6):e1008381
pubmed: 32525948

Auteurs

Sarah B Joseph (SB)

Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.

Sara Gianella (S)

Department of Medicine, Division of Infectious Disease and Global Public Health, University of California, San Diego, La Jolla, California, USA.

Tricia H Burdo (TH)

Department of Microbiology, Immunology and Inflammation, Center for NeuroVirology and Gene Editing, Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania, USA.

Paola Cinque (P)

Unit of Infectious Diseases, San Raffaele Scientific Institute, Milano, Italy.

Magnus Gisslen (M)

Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Department of Infectious Diseases, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden.

Scott Letendre (S)

Department of Medicine, Division of Infectious Disease and Global Public Health, University of California, San Diego, La Jolla, California, USA.

Avindra Nath (A)

National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA.

Susan Morgello (S)

Departments of Neurology, Neuroscience, and Pathology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Lishomwa C Ndhlovu (LC)

Department of Medicine, Division of Infectious Diseases, Brain and Mind Research Institute, Weill Cornell Medicine, New York, New York, USA.

Serena Spudich (S)

Department of Neurology, Yale School of Medicine, New Haven, Connecticut, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH